DNTH
Dianthus Therapeutics, Inc. /DE/
NASDAQ · Healthcare · Biotechnology · US
$85.79
+3.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2999.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.09x
- Price / sales
- 2520.19x
- Price / cash flow
- -30.88x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 2055.10x
- EV / EBITDA
- -132.51x
- EV / EBIT
- -17.96x
- Market cap
- $4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026